Literature DB >> 17828734

Effect of P-glycoprotein expression levels on the concentration-dependent permeability of drugs to the cell membrane.

Yoshiyuki Shirasaka1, Toshiyasu Sakane, Shinji Yamashita.   

Abstract

The purpose of this study is to develop a kinetic model that can predict the in vivo absorption of P-glycoprotein (P-gp) substrates from in vitro data. Apical (AP) to basal (BL) absorptive permeability of typical P-gp substrate drugs including quinidine, verapamil, vinblastine, and digoxin, were measured in several cell monolayers with different levels of P-gp expression, normal, P-gp induced, P-gp highly induced and MDR1-knockdown Caco-2 cells and MDR1-MDCKII cells. In all cell monolayers, AP to BL permeability of P-gp substrates increased when their AP concentration was increased, showing a sigmoid-type relationship to donor (AP) concentrations. At the higher concentration range, permeability reached a maximum value, suggesting saturation of P-gp-mediated efflux, and at the lower concentration range, permeability decreased depending on P-gp expression level. A simple kinetic model was applied to the permeability-concentration curve of each drug to obtain the fundamental parameters for P-gp-mediated transport, K(m(app)) and V(max). Both K(m(app)) and V(max) of each drug were found to show linear correlations with expression level of P-gp. This study clearly demonstrated the possibility to estimate the permeability of P-gp substrate drugs in human intestine from the expression level of P-gp, and thus the possibility to predict oral absorption of those drugs. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17828734     DOI: 10.1002/jps.21114

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  19 in total

1.  Use of different parameters and equations for calculation of IC₅₀ values in efflux assays: potential sources of variability in IC₅₀ determination.

Authors:  Donna A Volpe; Salaheldin S Hamed; Lei K Zhang
Journal:  AAPS J       Date:  2013-12-13       Impact factor: 4.009

2.  Predicting efflux ratios and blood-brain barrier penetration from chemical structure: combining passive permeability with active efflux by P-glycoprotein.

Authors:  Elena Dolghih; Matthew P Jacobson
Journal:  ACS Chem Neurosci       Date:  2012-12-11       Impact factor: 4.418

3.  Prediction of Drug Clearance from Enzyme and Transporter Kinetics.

Authors:  Priyanka R Kulkarni; Amir S Youssef; Aneesh A Argikar
Journal:  Methods Mol Biol       Date:  2021

4.  Prediction of nonlinear intestinal absorption of CYP3A4 and P-glycoprotein substrates from their in vitro Km values.

Authors:  Tatsuhiko Tachibana; Motohiro Kato; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2011-09-13       Impact factor: 4.200

Review 5.  Challenges of using in vitro data for modeling P-glycoprotein efflux in the blood-brain barrier.

Authors:  Noora Sjöstedt; Hanna Kortejärvi; Heidi Kidron; Kati-Sisko Vellonen; Arto Urtti; Marjo Yliperttula
Journal:  Pharm Res       Date:  2014-01       Impact factor: 4.200

6.  Model analysis of the concentration-dependent permeability of P-gp substrates.

Authors:  Tatsuhiko Tachibana; Satoshi Kitamura; Motohiro Kato; Tetsuya Mitsui; Yoshiyuki Shirasaka; Shinji Yamashita; Yuichi Sugiyama
Journal:  Pharm Res       Date:  2010-02-05       Impact factor: 4.200

7.  Real-time imaging and quantitative analysis of doxorubicin transport in a perfusable microvessel platform.

Authors:  Max I Bogorad; Peter C Searson
Journal:  Integr Biol (Camb)       Date:  2016-08-15       Impact factor: 2.192

Review 8.  ITC recommendations for transporter kinetic parameter estimation and translational modeling of transport-mediated PK and DDIs in humans.

Authors:  M J Zamek-Gliszczynski; C A Lee; A Poirier; J Bentz; X Chu; H Ellens; T Ishikawa; M Jamei; J C Kalvass; S Nagar; K S Pang; K Korzekwa; P W Swaan; M E Taub; P Zhao; A Galetin
Journal:  Clin Pharmacol Ther       Date:  2013-02-25       Impact factor: 6.875

9.  Cell-based multiscale computational modeling of small molecule absorption and retention in the lungs.

Authors:  Jing-Yu Yu; Gus R Rosania
Journal:  Pharm Res       Date:  2010-01-23       Impact factor: 4.200

10.  Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp).

Authors:  Yoshiyuki Shirasaka; Yan Li; Yuta Shibue; Erika Kuraoka; Hildegard Spahn-Langguth; Yukio Kato; Peter Langguth; Ikumi Tamai
Journal:  Pharm Res       Date:  2008-11-12       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.